* It is an advanced stage of macular type of lepromatous
leprosy with easily visible infiltration.
A possible explanation of this phenomenon is reduced release of vasoactive amines and reduced substance Pmediated immunostimulation and cellular proliferation, which results from reduced neuropeptide release because of nerve damage in lepromatous
skin lesions (11).
Pancytopenia due to lepromatous
involvement of the bone marrow: Successful treatment with multidrug therapy.
Waters, "Evidence for circulating immune complexes in lepromatous
leprosy," The Lancet, vol.
The appearance of "pudgy" deformed fingers is certainly misleading, but it may constitute an unsuspected inaugural form of leprosy, especially in its lepromatous
(d) Indeterminate leprosy, GRP78/BiP antibody; (e) tuberculoid leprosy, GRP78/BiP antibody; (f) lepromatous
leprosy, GRP78/BiP antibody; (j) indeterminate leprosy, PERK antibody; (k) tuberculoid leprosy, PERK antibody; (l) lepromatous
leprosy, PERK antibody; (g) indeterminate leprosy, IRE1[alpha] antibody; (h) tuberculoid leprosy, IRE1[alpha] antibody; (i) lepromatous
leprosy, IRE1[alpha] antibody; (a) indeterminate leprosy, ATF6 antibody; (b) tuberculoid leprosy, ATF6 antibody; (c) lepromatous
leprosy, ATF6 antibody.
(2004) had similar case numbers with confirmed neuropathic pain, using the same exclusion criteria, clinical presentation (lepromatous
leprosy), pain assessment procedures and also the McGill Pain Questionnaire.
On the other hand lepromatous
leprosy seen in patients with poor cell mediated immunity tends to cause multiple, asymmetrical skin lesions with irregular margins .
Type 2 reaction is observed in borderline lepromatous
leprosy and, usually, presents as crops of erythematous tender nodules and plaques over extremities, trunk, face, and other body parts.
The 1978 data were presented separately for contacts of "lepromatous
" (three arms: placebo, low dose, and usual dose) and of "non-lepromatous" index cases (two arms: placebo and dapsone).
The NOD2 pathway was inhibited and could not be activated in lepromatous
leprosy, which is more serious and causes widespread infection throughout the body.
In a study conducted on 2,517 patients in Dhaka, Bangladesh, it was observed that 2.1% patients suffered from Indeterminate form of leprosy, 52.7% suffered from tuberculoid form, 17.4% suffered from borderline tuberculoid form, 4.4% suffered from borderline lepromatous
form, and 23.4% suffered from the lepromatous
form of the disease (Choudhury, A.M., 1991).